acmefirewoodis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any thoughts on how many millions of new shares will be available tomorrow to be dumped on the market?
Plus it should be easier for the shorts to sell the new shares.
Is this a logical assumption?
Was ScottTrade the only brokerage holding up shares being available?
.075 by Friday.
It's overbought here.
1,000,000,000 is a lot of shares.
IMHO.
I think $170,000,000 market cap is too high.
IMHO.
Lock in your profits before the next dump happens.
.07 is the support level.
Just saying.
I've made money trading AMBS everyday.
Don't worry about me.
This is due for another sell-off. It's happened every time and it will happen again.
1,000,000,000 shares is a lot of shares.
p.s. Remember when it went from .169 to .014 just a few weeks ago?
.075 by Friday.
Just saying.
It's too expensive here.
I expect this will be in the .06 vicinity within two weeks.
Time will tell.
GLTA
p.s. I noticed there's a buy order on level 2 for 5,000,000 shares at .013. I guess someone wants in on the cheap side.
$135,000,000 market cap is too high.
Based on the 1,000,000,000 shares eventually being sold.
It appears that the stock is still trading in the "land of the naked shorts".
Very good for volatility.
GLTA
MANF could be $1,700,000,000 and fifteen years from reaching the market in some form as a useful drug.
About one in 5,000 drugs make it from pre-clinical tests to F.D.A. approval.
Unless the company finds a partner this is substantially overvalued currently.
http://www.pdpipeline.org/2011/Eithics/navagating/regulatory.htm
"Pigs get fat and hogs get slaughtered."
Volatility rules penny stocks.
Interesting weeks ahead.
"Buy on the rumor sell on the news."
p.s. This is overdue for a classic bear raid. I think it could retest the .065 level or lower.
GLTA/IMHO
MANF could be $1,700,000,000 and fifteen years from reaching the market in some form as a useful drug.
About one in 5,000 drugs make it from pre-clinical tests to F.D.A. approval.
Unless the company finds a partner this is substantially overvalued currently.
http://www.pdpipeline.org/2011/Eithics/navagating/regulatory.htm
"Pigs get fat and hogs get slaughtered."
Volatility rules penny stocks.
Interesting weeks ahead.
I think he spends his free time looking for footprints on the "grassy knoll".
Just saying.
Interesting week ahead for the shareholders.
First revenue report and an update of the company's plans going forward into 2013 would meet my expectations.
.10 within three months is quite reasonable.
"Show us the gold!!!"
Exciting year ahead for the company.
I think this could be at $3.00 by the end of 2013.
Happy New Year to everyone!!!
"Happy New Year" to everyone!!!
I hope that everyone has a healthy and prosperous 2013!!!
Be back next year. :)
Let's see if it can go above .06 next week. :)
"Happy New Year" ahead for all the "BONZ" faithful.
I'm expecting the first gold revenue numbers next Tuesday or Wednesday. Also the company should issue an update on its future plans for expanding gold production at the Tarantula site.
I do think the right news could move this to the .06-.08 range.
Next week should brings some very good news to the shareholders.
Good luck to all the "BONZ" faithful both old and new.
.06-.08 would be a reasonable price target.
p.s. In regards to price targets with penny stocks someone should never say that a certain "reasonable" price target will never happen.
"Poison Pill" plan was a stupid move by management. Best way to stop speculative upward momentum especially with the company having another 750,000,000 shares to dump on the market.
I may re-buy when it goes back below .04.
End of day dump expected. Shorts are just waiting for a few more newbies to buy.
I'm thinking it hits .048 and closes at .055.
Poison bill news sucks for the retail investors.
Take some profits before it happens.
p.s. Last time it dropped to .0145.
What time will the 20,000,000 share dump happen?
Any thoughts?
New SeekingAlpha article:
http://seekingalpha.com/article/1088021-today-s-market-news-to-trade-on-5-stocks-we-are-watching-heading-into-2013?source=yahoo
I'm thinking that $25.00 or higher by the end of 2013 is reasonable.
GLTA
With management expecting a lower share price as the company sells more of the additional 750,000,000 shares the "poison pill news" was expected.
Volatility will continue.
Current share price would equate to $110,000,000 market cap with all 1,000,000,000 shares issued.
The series "B" preferred stock converts to 125,000,000 shares which I assume are owned by Gerald.
Does anyone know what the conversion is for the series "A" preferred shares? Possibly another 100,000,000 shares to Gerald?
A .10 share price with 1,000,000,000 shares outstanding is a $100,000,000 market cap.
$800,000,000 investment and 80 months to an F.D.A. decision?
http://www.pdpipeline.org/2011/Eithics/navagating/regulatory.htm
Support at .035. I don't think it will go below .035 again.
The company lost almost $3,000,000 in the first nine months of 2012 with only three employees.
Supposebly the company spent over $2,000,000 on consulting services in the first nine months of 2012. Possibly someone could explain who might be the consultants that commanded such large payments.
Were any of these consultants previously associated with Amgen?
For one thing it takes the "BS" out of "AMBS".
"Buy on the rumor and sell on the news."
Volatility rules.
If you don't think this will go below .05 again I think you are ignoring the trading pattern.
Gerald will receive 125,000,000 shares when the class "B" preferred stock converts? At .10 a share that's $12,500,000. Not bad for conducting a study on a few rats.
Trade the volatility and make a few dollars.
The "Penny Stock Casino" is open for business.
GLTA
$800,000,000 and seven years:
http://www.pdpipeline.org/2011/Eithics/navagating/regulatory.htm
What drug does AMBS have in phase 1 trials?
Could you please post a link?
Read this study from 2009 which didn't really find any major differences but suggested additional studies were warranted.
http://www.jneurosci.org/content/29/30/9651.full
I think that in the instances that you cited the companies were generating revenue where as the MANF technology is a minimum of seven years and a minimum of an $800,000,000 investment to get to that situation if it happens:
http://www.pdpipeline.org/2011/Eithics/navagating/regulatory.htm
Time will tell.
GLTY
At .10/share the 125,000,000 shares are worth $12,500,000 currently.
With that kind of pay-out ahead Gerald should be very nice to the shareholders.
There may be a provision to convert the preferred "B" shares earlier under certain circumstances. If anyone finds such a provision please reference it in a post.
Also any information about conversion rate for the convertible "A" series shares would be appreciated.
That was probably the consultant's fee that Amarantus paid him.
Check the quarterly filings and look at the amount of money the company has spent on consulting services. Over $2,000,000 this year?
No I haven't. I expected them to be reported about 4-6 weeks after the start of full production which was delayed.
My expectations are still on track. Situations change and one must learn to adjust.
Many will miss buying at the bottom, again. :)
I would assume that Gerald is the holder of the preferred "B" shares which will convert to 125,000,000 shares.
I'm certain he won't sell those. :)
http://www.faqs.org/sec-filings/120820/Amarantus-BioSciences-Inc_10-Q/ex3_1.htm
Does anyone know what the conversion is on the series "A" preferred shares?
He gives the current shareholders a "poison bill" which will stop speculative momentum while he's looking at 125,000,000 shares to be issued to himself "down the road".
Gerald has the shareholder's best interest at heart.
p.s. Now you know why the company needs a billion shares authorized.
It's obvious that the company needed the additional time to try to put a positive spin on the data.
The "poison pill" news will kill the upward momentum. It essentially stops any shares accumulation by any outside entity that may want to attempt a takeover.
It does protect the value of the Class B preferred shares that convert into 125,000,000 shares of common stock. I assume these shares are owned by Gerald.
Self preservation is important to the insiders with penny stock companies.
Will support at .035 hold on Monday?
I'm expecting the first gold revenue report to be on January 9th.
It's my understanding that the unit was "calibrated" and in "full" gold production starting on December 3.
I'd be disappointed if the revenue news plus an updated overview of the company's future plans doesn't move the share price to .06 or higher.
Don't discount the possibility that the financing agreement with Tonaquint, Inc. may be terminated and replaced with new financing that is substantially potentially less dilutive. It's my understanding that none of the first tranche received from Tonaquint has been converted to shares and the intent of the company's management is to insure that it doesn't happen.
We will know soon enough.
Good luck to all the "BONZ" faithful both old and new.
p.s. I don't know of any other stocks that have the potential to double or triple in price over the next two weeks.
Another day of "underwater" buyers. That can't be good. Lots of overhang for any attempted move higher.
Just placed a buy order at .035.
Wish me luck.
Major catalysts in January will move the share price substantially higher.
It's tremendously oversold here.
Closing the year in the .055 range.
Nice profit for many.
GLTA
p.s. Delaying releasing the MANF study results created doubt for the shareholders.